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Abstract
Background: Cancer is one of the most dreadful diseases present in today’s world. It is
responsible for millions of deaths worldwide. The disease is debilitating to one’s physical and
emotional well-being. Cancer impacts not only the affected individual but also those close to
them. When colorectal cancer is identified early via preventive screenings, it has a greater chance
of responding to treatment, therefore, increasing the chances of survival. The fecal
immunochemical test (FIT) kit plays a pivotal role in the early detection of colon cancer.
Schreuders et al. (2016) revealed that FIT kits have better adherence, usability, and accuracy,
citing that FITs either provide a qualitative calculation or quantitative calculation in terms of
fecal hemoglobin concentration per gram of feces. Schreuders et al. (2016) further supported
preventive screenings noting the high occurrence and related mortality with the typically slow
progression of colorectal cancer renders colorectal cancer remarkably suitable for population
screening via FIT kits. Many of the key findings from the literature review revealed that utilizing
multimodal communication strategies enhanced patient participation and compliance in
colorectal preventive screenings.
Purpose: The purpose of this DNP project was to improve the return rate of fecal
immunochemical test (FIT) kits by implementing multimodal communication strategies.
Methods: Multimodal communication strategies utilize various forms of communication such as
verbal, text/email, and written forms such as letters. The goal of this project was to demonstrate
that utilizing multimodal communication strategies will increase patients’ willingness to return
fecal immunochemical test (FIT) kits.
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Results: Key results revealed that of the seven kits issued post-intervention (March), there were
three (42.9%) returned. There was no statistically significant difference between the proportion
of kits returned pre-intervention versus post-intervention (p=0.239).
Conclusion: The project aided in increasing the number of screened patients for colorectal
cancer; however, the project’s results did not show an increase in the return rate of FIT after
implementing multimodal communication strategies.
Keywords: colorectal cancer screenings, colon cancer, preventive screenings, fecal
immunochemical test (FIT) kits, multimodal communication strategies
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Utilizing Multimodal Communication Strategies to Improve Average Risk Women Veteran
Patient Participation in Returning Colorectal Fecal Immunochemical Test kits
The diagnosis of cancer can be a life-changing experience. It is responsible for millions
of deaths worldwide. The disease is debilitating to one’s physical and emotional well-being.
Cancer impacts not only the affected individual but also those close to them. Although cancer
affects people of all sexes, ethnicities, and races, it does not always impact them equally.
The American Cancer Society (2022) defines cancer as the process in which your body’s
old or abnormal cells that usually die at a certain point in time, live on to out-grow healthy or
normal cells. Some cancers grow and spread rapidly, while others are slow or remain stagnant.
When cancer is identified early, for instance, through preventive screenings, it has a greater
chance of responding to treatment, increasing survival chances. The purpose of this Doctor of
Nursing Practice (DNP) project aimed to focus on the return of fecal immunochemical test (FIT)
kits for colorectal cancer (CRC) screenings. Colorectal cancer refers to a cancerous tumor or
tissue growth that begins in the colon or rectum. Siegel et al. (2020) noted that colorectal cancer
is currently the second most common cause of cancer death in the United States.
Abancens et al. (2020) noted that a lower incidence of colorectal cancer is found in
females compared to males. According to the American Cancer Society (2022), the lifetime
probability of developing colorectal cancer is about 1 in 25 (4.0%) for females and 1 in 23
(4.3%) for males. Healthy lifestyle habits, including smoking cessation, sustaining a healthy
body weight, being physically active, reducing alcohol intake, and consuming a nutritious diet,
have been associated with a significant reduction in colorectal cancer incidence and mortality
(Wang et al., 2021). Preventive screenings such as fecal immunochemical test (FIT) kits are

another tool that has proven effective in reducing colorectal cancer mortality.
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Background
The World Health Organization (WHO) (2021) noted that between 30 and 50% of
cancers could presently be prevented by implementing current evidence-based prevention
strategies such as preventive screenings and avoiding known risk factors. One of those
preventive screenings is FIT kits for colorectal cancer screenings. Schreuders et al. (2016)
revealed that guaiac fecal occult blood tests were first widely used in the 1970s for populationbased colorectal cancer screening. The goal of preventive screenings is to improve patients’
overall health, not only to diagnose disease processes. Bell et al. (2017) stressed that highly
trusted guidelines should provide data on both the benefits and harms accompanying preventive
health screenings and knowledge interpretation tools to assist collective decision-making with
patients. Although guaiac fecal occult blood tests (gFOBT) have high specificity, its sensitivity is
relatively low (Bell et al., 2017). In contrast, FIT kits are more sensitive in detecting hemoglobin
than gFOBT with reported sensitivities for advanced neoplasia discovery of two to three times
greater compared to gFOBT (Bell et al., 2017). In the study conducted by Conn et al. (2020),
multimodal communication strategies were used to increase the return rate of FIT kits noting an
increase in return rate to 60.7% from 41.1%.
Needs Analysis
For colorectal cancer screenings via FIT kits to be of any benefit, the kit must not only be
explained and dispensed properly but also completed appropriately and returned by the patient
for accurate testing. During a local needs analysis, it was revealed that many female veterans at a
southeastern Veteran Affairs Medical Center were noncompliant with returning their FIT kits for
evaluation. Raw data from the medical center revealed that the total return rate of FIT kits issued
to primary care patients was 36.21% as of November 2021. It is particularly important for this
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population to complete preventive screenings as Purcell et al. (2021) noted that when compared
to the general population, veterans assisted by the Veteran Affairs (VA) healthcare system have
more health conditions such as cancer, are older, and also suffer disproportionately from mental
health conditions. These patients have courageously and selflessly served their country and thus
deserve quality healthcare. It would be undeserving to this vulnerable population to notice a gap
in service without a proposal for change. The goal of this project was to implement a process
improvement plan within the Veteran Affairs women’s clinic that addresses the non-compliance
of returning FIT kits.
Fecal Immunochemical Test (FIT)
Doubeni et al. (2016) describe the FIT kit as a “newer fecal occult blood test that uses a
specific antibody for human hemoglobin” (p. 2). Blood in the stool can be an early sign of colon
cancer; however, it cannot be seen with the naked eye. The FIT kit detects blood in the stool that
the visual eye may not see. The FIT test is a noninvasive procedure that can be performed within
the comforts of the patient’s home. Completing the FIT test involves patients sampling their
stool using the wand in the kit and returning it to the appropriate facility. This test needs to be
repeated every year.
Each testing kit contains a prepaid postage envelope, the sampling bottle, biodegradable
paper, and a plastic biohazard bag. The directions listed by Polymedco (2008) for sample
collection are as follows:
1. Place supplied collection paper inside the toilet bowl on top of the water.
2. Deposit stool sample on top of the collection paper.
3. Open the cap by twisting and lifting.
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4. Scrape the surface of the fecal sample with the sample probe, covering the
grooved portion of the sample probe completely with stool.
5. Collect sample from the stool before the paper sinks, and the stool sample touches
the water.
6. Close the sampling bottle by inserting the sample probe and snapping the green
cap tightly. Do not reopen.
7. Wrap the sampling bottle in the absorbent pad, insert it into the plastic bag, and
then the envelope.
8.

Promptly return to the lab either in person or using the prepaid postage envelope.
Problem Statement

A literature review revealed that colorectal screening FIT kits are being given to patients
but not returned. Therefore, patients are not adequately screened for colorectal cancer. At this
investigator’s project facility, protocols are currently being drafted for nurses to follow up with
FIT kits that have been given in the clinic or mailed out. This student’s goal is that an effective
standard operating procedure utilizing multimodal communication strategies will be established
in the VA clinics nationwide to ensure the return of the FIT kits. Based on an initial need
assessment, a multimodal outreach strategy will be developed.
This DNP student developed a PICOT question based on the need assessments and
literature review. The PICOT question approach includes the DNP student considering the
population (P), Intervention (I), Comparison (C), and Outcome (O). For the purposes of this
study, the question being assessed was among average risk veteran women patients (P), does
implementing a multimodal outreach strategy (I), as compared to no intervention (C), increase
the return of completed Fecal Immunochemical Test kits (O).
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Aims and Objectives
The aims of this project were two-fold:
a) To improve the return rate of FIT kits through increased participation in preventive
colorectal cancer screenings among a female veteran population that seeks their
medical services through a medical facility that serves veterans that have served in
the United States military; and
b) To implement a standard protocol for utilizing multimodal communication strategies
among multimodal communication strategies among patients through the utilization
of a combination of verbal, text, secure messaging via emails and letters to
communicate with patients.
Review of Literature
An analysis and synthesis of literature were performed for the DNP project. The review
of literature was performed considering screenings utilizing FIT kits and implementing
multimodal communication strategies to increase compliance. The search engine databases used
were Google Scholar, PubMed, and CINAHL. The keywords utilized in the database were:
colorectal cancer screenings, colon cancer, preventive screenings, women, veteran, fecal
immunochemical test (FIT) kits, and multimodal communication strategies.
The American Cancer Society (2022) emphasizes the importance of colorectal screening
and notes that many deaths from colorectal cancer could possibly be prevented had more
individuals had the recommended screening test to detect colon cancer early. The American
Cancer Society (2022) further notes that even if cancer arises, it is likely to be easier to treat if
found early during preventive screening. This literature review revealed significant key findings
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that stressed the importance of preventive colorectal screenings along with similar
methodologies utilized in this DNP project to increase patient participation.
Sexual Dimorphism
Abancens et al. (2020) conducted a review of several studies to reveal sexual dimorphism
in colon cancer. The authors noted that combination estrogen, progesterone, and hormone
replacement therapy were analyzed in a 2012 meta-analysis based on eight cohort studies, four
randomized trials, and eight case-control studies, including data of postmenopausal women,
collected from the United States, European Union, and Canada. This study took place between
1965 and 2006 and had a follow-up range of 3–15 years. The review revealed that the findings
from this meta-analysis confirmed that both estrogen-alone and estrogen plus progesterone
therapy decreased colon cancer risk by 30% (Abancens et al., 2020). The authors also noted that
a double-blind, randomized clinical trial executed in the early 2000s by the Women’s Health
Initiative (2013) showed that combined therapy of estrogen plus synthetic progesterone caused a
38% reduction in colon cancer, noting that the protection did not remain in the follow-up years
of the trial (Abancens et al., 2020). These findings are significant because they support the lower
incidence of colorectal cancer found in females compared to males. These findings are
significant to this DNP project as the project focuses solely on women patients. In the review
conducted by Abancens et al. (2020), it was noted that even with similar lifestyle choices, it
seems that women sustain a higher level of protection against colorectal cancer than men,
associating sexual dimorphism as a critical component in future studies and therapeutic
strategies. Abancens et al. (2020) revealed that critical proliferative pathways in CRC
tumorigenesis revealed sexual dimorphism, which presents better survival rates in females
through cell signaling and estrogen-regulated genes.
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Benefits and Harms
In the review conducted by Bell et al. (2017), evaluations from The National Lung
Screening Trial, European Randomized Study on Screening for Prostate Cancer, computed
tomography and prostate-specific antigen tests were used to determine the rate of overdiagnoses.
The authors revealed harms related to false-positive test results include stress and anxiety
associated with the diagnosis of the disease, as well as harms related to the extra testing essential
in determining the presence or absence of a disease or condition (Bell et al., 2017). Conditions in
which preventive health guideline recommendations offer strong evidence that the favorable
effects of an intervention outweigh the unfavorable effects or benefits, providers can be certain
that most patients would be best helped by following the guidelines (Bell et al., 2017). In
addition, providers could be certain that most patients would be served well by following the
guideline recommendation. The findings lacked strong evidence indicating that different
methodologic approaches were used to calculate estimates. These findings were not significant to
this student’s DNP project as specific colorectal cancer estimates were omitted. However, the
results raised awareness that studies need to be inclusive to address qualitative data such as
anxiety and stress related to patients’ apprehension of completing preventive screenings.
Colorectal Screening Program Intervention and Implementation
In an in-depth analysis conducted by Conn et al. (2020), 12 federally qualified facilities
implemented a reminder protocol for FIT kits issued. The purpose was to boost colorectal cancer
screenings to 80% or at least 10% of baseline screening rates at the participating facilities (Conn
et al., 2020). In this study, the use of reminders was examined to determine if phone calls and
reminder letters encouraged the return of FIT kits. The initial rate of compliance was compared
with the return rate. Results noted that of 5,041 FIT kits issued, the initial compliance rate was
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41.1% prior to any interventions. Furthermore, 2,201 patients received reminders, resulting in a
total average return rate of 60.7%, improving the FIT return rate by 19.6%. These findings were
significant to this DNP project because the interventions implemented in the study were very
similar to the interventions implemented by this DNP student. Also, the positive results from this
study provide evidence to have the facility support sustainability of this student’s DNP project.
In the study conducted by Conn et al. (2020), a powerful lesson learned was the value of having
superior electronic systems in position that can sustain tracking patients in the current time to
circumvent the need for a large volume of staff’s time to manually screen patients for colorectal
screening programs.
Crosby et al. (2016) noted that an outreach-based colorectal cancer screening program in
a rural environment might produce high return rates. In this study, 345 participants were
recruited via a community outreach program to determine who would return FIT kits. Eighty-two
percent of participants returned the kits. Of the returned kits, 68.4% were female, and 340
participants identified as Caucasian. A significant finding of this study was that those reporting
an annual income of less than $15,000 per year were more likely to return to the kits at 89.8%.
Also, those who stated they did not have a regular primary care provider were more likely to
return the kits (92.3%) when compared to those who did have a primary care provider (79.9%).
One major limitation of this study was that it was conducted out of convenience of the
participants. However, the findings were noteworthy, citing that women are more likely to return
the FIT kits, although current data shows that men have a higher incidence of colorectal cancer
(Crosby et al., (2016).

Gupta et al. (2020) revealed that mailed FIT kits propose potential for increasing
screening rates, but ideal strategies for execution have not been well created. In the review of a
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Centers for Disease Control and Prevention summit conducted by Gupta et al. (2020), numerous
observational and randomized controlled trials were examined and proved that mail outreach
programs offering FIT tests were successful and effective. The summit’s purpose was to gather a
group of experts to review evidence for mailed FIT outreach methods, best practices for
execution and to summarize the disparities in the research literature. The summit’s attendees
reviewed a per-protocol analysis conducted by Schlichting et al. (2014), who reported an 85%
FIT return rate in a sample of 190 veteran patients who were sent a preliminary letter, received a
call from a live person, agreed to be sent a FIT test, and followed by additional telephone
reminders. One limitation that the summit noted regarding letters is that published literature on
the comparative effectiveness of the letter’s content was inadequate. However, suggestions were
made to include a return contact number for questions, provide information in the patient’s own
language, and simple writing in giant print for patients with literacy deficits. A reminder was
noted that the effectiveness of the mailed FIT programs with colorectal outcomes relied upon a
complete follow-up for abnormal stool test results. Overall, these findings were exceptionally
noteworthy for this student’s DNP project as it supports the effectiveness of utilizing multimodal
communication strategies to increase the return of colorectal FIT kits.
The qualitative study conducted by Liles et al. (2015) explored 55 stakeholder viewpoints
regarding implementing a population-based colorectal cancer screening program. These
stakeholders consisted of 20 primary care providers, eight health plan leaders, 23 endoscopy
specialists, and four program managers. Liles et al. (2015) noted that a third-party qualitative
methodologist conducted professionally transcribed interviews for analysis. In the interviews,
health plan leaders advocated utilizing a multimodal approach in screening patients during visits
and conducting automated phone calls to improve screening rates (Liles et al., (2015). One
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barrier that primary care providers noted during this study was the lack of support by specialists
and health plan leaders when patients were referred for colonoscopy in average-risk patients. All
stakeholders assumed some providers believed that colonoscopies are the only appropriate
method for colorectal cancer screening for average-risk patients (Liles et al., (2015). Health plan
leaders recognized the multimodal approach to offering screening possibilities to patients (i.e., at
patient visits (in-reach) and via automated calls (outreach) as significant characteristics of
enhanced screening rates (Liles et al., (2015). A limitation of this study was that stakeholders’
responses represented true feelings due to being interviewed. A great strength of this study was
that it collected viewpoints of individuals who were in a position to assist with implementing a
successful population-based colorectal cancer screening program.
In the pragmatic randomized trial conducted by O’Connor et al. (2020), 26 clinics serving
low-income populations of 30,667 patients were randomized by a computer-generated
randomization strategy with a one-to-one ratio. O’Connor et al. (2020) noted that tools were
created to enable clinics to use the electronic health record to create mailing lists along with
materials for the following: (a) a preparatory letter, (b) a FIT kit with instructions specifically
created for poor-literacy and non-English-speaking populations, and (c) a reminder letter. The
FIT completion in the intervention group ranged from 15 and 25%, predictably three to six
percentage points greater than control group participants (O’Connor et al., 2020). One major
limitation noted in the study was the sole reliance on the electronic health record for moderator
variables that may not have been accurate or misclassified. The strength of this study was the
pragmatic effectiveness trial, operated in real-world safety net clinics, utilizing existing staff and
structure (O’Connor et al., 2020). Responses to a mailed FIT intervention were commonly
constant across a wide range of individuals and neighborhood-level patient attributes, including
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typically underserved patients and those in low-means communities (O’Connor et al., 2020). One
significant relevance of the article to this student’s DNP project is the reliance on electronic
health records to identify patients due for colorectal screening. However, due to the DNP project
being conducted in a federal facility that takes pride in up-to-date and reliable electronic health
record systems, this student is confident in relying on the electronic system for accurate
monitoring and data.
Costs Associated with Mailed FIT Kits
In the program conducted by Kemper et al. (2018), the objective was to assess whether a
mailed FIT program could be executed at a reasonable cost that would allow sustainability of
practice. Kemper et al. (2018) noted that The Washington State Department of Health partnered
with HealthPoint, a large federally qualified health system, to implement a direct-mail FIT
program at nine medical clinics. The program included following up with a reminder letter and
automated telephone calls to individuals not compliant with recommended screening. According
to Kemper et al. (2018), a total of 5,178 kits and 4,009 reminder letters were mailed, along with
8,454 automated reminder telephone calls placed. The average total cost per FIT kit returned was
$39.81, which included the development and intervention phase, management oversight, and
data quality assessment (Kemper et al., 2018). The study’s findings were that 31.0% of those
who received the FIT kits completed the screening. One of the limitations of the conclusions was
that HealthPoint only tracked patients’ language preferences and health information associated
with the FIT screening while disregarding patient characteristics. This limitation was significant
to this student’s DNP project as the project’s inclusion is only women. However, the project
provided insight into possible costs associated with implementing such a program. The cost of a
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FIT kit screening is $39.81, whereas the average per capita expenditure for colon cancer care is
$60,321, according to Eaglehouse et al. (2019).
Fecal Testing
In the retrospective cohort study conducted by Doubeni et al. (2016), the relation of
ambient temperature exposure with FIT sensitivity and positivity rate was examined. The cohort
study included 510,922 patients and 1,429,089 qualified FITs over a 7-year study timeframe. The
study revealed that exposure of FIT specimens to high ambient temperatures is correlated with
reduced FIT sensitivity and positivity rate for detecting colorectal cancer. FIT positivity rates
were substantially lower in weeks with higher temperature degrees when compared with the
lower temperature weeks. Doubeni et al. (2016) suggest revising kit designs and specimen
transportation methods, displaying visible warnings on the kits about heat sensitivity, and other
techniques for minimizing high-temperature contact to help enhance FIT performance. However,
it was also noted that these actions might increase testing difficulty and decrease patient
adherence, thus necessitating careful study (Doubeni et al., 2016). These findings were
significant to this student’s DNP project due to FIT kits being mailed and patients testing their
samples in their homes, thus eliminating a controlled setting to monitor the temperatures of the
FIT kits.
In the article by Schreuders et al. (2016), the advantages and disadvantages of guaiac
fecal occult blood tests (gFOBT) are compared to FIT kits. Schreuders et al. (2016) noted
although gFOBT has a high-level specificity, its sensitivity is inadequate since it does not detect
hemoglobin levels below approximately 600 μg/g of feces. The authors revealed that FIT kits
have greater adherence, usability, and precision as compared to gFOBT, citing that FITs either
provide a qualitative calculation such as pass or fail results or quantitative calculation in terms of
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fecal hemoglobin concentration per gram of feces (Schreuders et al., 2016). Preventive screening
was supported by Schreuders et al. (2016) noting the high prevalence and associated mortality
and the ordinary history of colorectal cancer with slow advancement from a premalignant polyp
to cancer, rendering colorectal cancer exceptionally suitable for population screening. This
article was of importance to this DNP project because it supports the use of FIT testing versus
the original guaiac fecal occult blood test.
Colorectal Cancer Statistics
In the article Colorectal Cancer Statistics, Siegel et al. (2020) interestingly noted that
although the CRC occurrence rate is 31% higher in men, the lifetime risk is comparable in men
(4.4%) and women (4.1%) due to women statistically living longer. Siegel et al. (2020) also
noted that frequency is comparable in those younger than 45 years of age, however, it is 40% to
50% higher in men than in women of ages 55 to 74 years. Siegel et al. (2020) further noted more
than one-half of all CRC cases and deaths were caused by modifiable risk factors, and a
significant amount could have been prevented through screening and surveillance. Guidelinecompliant screening frequency reached 66% in 2018 nationally; however, commitment remained
low in many states, among the uninsured, individuals ages 45 to 54 years, and those who had a
family history of the disease (Siegel et al., 2020). The statistics in this article that were
noteworthy were the mention of modifiable behaviors along with preventive screenings to reduce
the incidence of CRC.
A nationwide cohort study conducted by Wang et al. (2021) revealed captivating data that
suggested that 20% to 70% of CRC cases and deaths could possibly be prevented by following a
healthy lifestyle of maintaining an appropriate body mass index (BMI), smoking cessation,
increased physical activity, proper dieting, and limiting alcohol intake. The study’s results
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propose that approximately 32% of CRC cases and 34% of CRC deaths could possibly be
prevented by endoscopic screening solely (Wang et al., 2021). In conjunction with the five
healthy lifestyle factors, these statistics increased to 61% and 55%, respectively. One limitation
of the cohort study observed was that participants were all predominantly white health
professionals, which may not be typical of the general population.
Overall, the literature review revealed insightful guidance in implementing this student’s
DNP project. Many of the key findings from the literature review showed that utilizing
multimodal communication strategies enhanced patient participation and compliance in
preventive screenings. Unfortunately, the literature review revealed limited data regarding
compliance in returning colorectal FIT kits among female veteran patients. The review also
lacked substantial evidence-based data noting precise verbiage to include in introductory letters
and reminder calls to increase compliance with return rates.
Theoretical Model Utilizing Jean Watson’s Theory of Caring
Noel (2010), utilized Jean Watson’s Caring Theory as a theoretical framework for a
nursing model stating, that nursing is concerned with “promoting health, preventing illness,
caring for the sick, and restoring health” (p.18). According to the World Health Organization
(2021), the theory of cancer screenings is that a screening test should decrease mortality rates
from a particular condition without disproportionately harming people without the condition. Athome FIT kits are an appropriate screening tool that can be utilized in the preventive measures of
the nursing process.
Determining various ways to implement changes within an organization can be
challenging. To facilitate the success of an intervention, one must first have a plan with proven
effectiveness in place. For that reason, the Plan-Do-Study-Act Model (PDSA) will be followed
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to implement this student’s process improvement project. Morelli (2016) confirmed that the
PDSA model could prepare a solid foundation from which to initiate the process of quality
improvement by planning out what will be done, doing it, studying and analyzing the outcomes,
and acting on the outcomes to make improvements in the project.
Methodology
This principal investigator received prior authorization from Veterans Affairs and an
approval letter from Jacksonville State University’s internal review board (IRB) to complete this
DNP project (Appendix A). Prior to implementing the project, this DNP student also completed
the Collaborative Institutional Training Initiative (CITI) program (Appendix B). The DNP
student reviewed a panel of 804 women patients assigned to a southeastern Veteran Affairs
primary care clinic that seek their medical care from a medical center facility that specializes in
care of the military population. Currently, there are two providers in the women’s clinic who
each provide care for approximately 1,000 female patients. The average risk patients, in which
criteria are listed later in this manuscript, were evaluated to determine if they had been screened
for colorectal cancer. A FIT test was mailed to individuals that met inclusion average risk and
agreed to FIT testing.
Sample Size
From a panel of 804 women veteran patients, 97 (12.06%) were deemed ‘average risk’
for colorectal cancer and were either upcoming or past due for colorectal screening. Of the 97
‘average risk’ patient group, 27 (27.83%) patients were excluded due to refusals and recent or
future scheduled colonoscopies. Twenty-nine (29.89%) patients of the ‘average risk’ patient
group were unable to be reached via telephone and secure messaging attempts. The excluded,
unreachable, and refusal groups contributed to a decreased sample size of 41(42.26%) patients.
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From this group, the DNP student narrowed down the number of patients due for
colorectal cancer screenings via FIT kits for March. For March, 13 patients were due or past due
for colorectal cancer screenings, 6 of those patients were excluded due to not being reachable via
communication attempts, refusals, or having recent or future scheduled colonoscopies.
Therefore, 7 patients were screened and issued FIT kits for the month of March.
According to A Cancer Journal for Clinicians (2020), average risk patient criteria include
individuals aged 45-75 that DO NOT HAVE: (a) history of colorectal cancer or certain types of
polyps, (b) family history of inflammatory bowel disease, (c) confirmed suspected colorectal
cancer syndromes, such as familial adenomatous, (d) polyposis or Lynch syndrome, (e) history
of radiation to the abdomen or pelvic area to treat a prior cancer. Inclusion and exclusion criteria
for the DNP project can be found in Table 1.
Consent
Verbal consent was obtained from all participants before project implementation
(Appendix C). It was emphasized that the participant’s role was to complete the FIT kit;
however, there would be no consequences for not participating. The risks and benefits were
discussed, and the participants were allowed to voice any questions or concerns. The participants
were stressed that privacy and confidentiality of all identifiable information would be maintained
throughout the DNP project.
Design
Multimodal communication strategies were utilized to encourage patients to return the
FIT kits. These strategies included initially contacting the patient via telephone and secure
messenger, notifying of ‘average risk’ status. If the patient was unreachable by phone or secure
messenger, the patient was sent a primer letter (Appendix D) by mail and secure messenger. The
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primer and follow-up communication letters were created by the site’s colorectal cancer
coordinator and approved for official use prior to implementing the DNP project. The primer
letter informed the patient that she was deemed “average risk” for colon cancer and to contact the
primary care team if interested in FIT kit testing for colorectal cancer. If the patient was
contacted successfully and consented to complete the FIT kit, a FIT test was ordered and mailed
out to the mailing address verified by the patient. The patients were advised to return the FIT test
as soon as possible, preferably within 7 days. This student monitored the return of the FIT kits
for 14 days following the issuing of the kit. At the 14-day mark, patients who had not returned
the kits were given a follow-up call to encourage the return of the kit. The patient was mailed a
follow-up reminder letter if the patient could not be reached via telephone during the follow-up
phase (Appendix E). Concurrently, a follow-up reminder notice was also sent via secure
messenger. The follow-up letter reminded the patient that she was mailed a FIT kit on a specified
date; however, the facility hadn’t received it. The follow-up letter advised the patient to return
the kit as soon as possible or to contact the primary care team for a replacement if it was
misplaced.
After the follow-up letter was issued, this student monitored for the return of the FIT kits
for an additional two weeks. At the 30-day mark of the FIT kit being issued, the FIT order was
canceled per the facility’s policy due to no specimen being received.
Risks and Benefits
Lower risks of colorectal cancer are associated with smoking cessation, limiting alcohol
intake, increasing physical activity, following a healthy diet, and maintaining an appropriate
body mass index (BMI), according to Wang et al. (2021). When cancer is identified early, it has
a greater chance of responding to treatment, therefore, increasing the chances of survival. The
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benefit of participating will reveal if multimodal communication strategies are effective in
returning FIT kits.
The risks involved in not participating include not being adequately screened for
colorectal cancer on an annual basis. Participants may experience anxiety or nervousness while
sampling their own stool for collection. To minimize this risk, the DNP student ensured each
patient was provided full disclosure of the risks and benefits of colorectal screening.
Outcome Measurement
Outcomes were measured by comparing FIT kit return data post-intervention with preintervention data. The facility has an internal tracking and reporting tool that monitors patient
compliance in which this student was granted access. The pre- and post-intervention data were
compared using the Chi-squared test to determine the difference between the proportion of kits
returned pre- (February) and post-intervention (March). The test was performed using Stata
version 15.
In the month of February, a total of 16 FIT kits were issued, and 11 (68.8%) were
returned. An outlier of this was that an additional 17 patients were due for a colorectal screening
via a FIT kit for February; however, the screening was not completed, nor was a FIT kit issued.
Of the total number of patients (41) that were mailed FIT kits, 18 kits (43.90%) were returned.
For March only, 13 patients were due a screening. Three patients were excluded due to being
unreachable via telephone and secure messaging efforts. Three additional patients were excluded
due to refusal and recent and future scheduled colonoscopies. Therefore, 7 FIT kits were mailed
out to patients. For the month of March, 3 (42.9%) FIT kits were returned.
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Results
Of the 16 kits issued pre-intervention, there were a total of 11 (68.8%) returned, and of
the 7 kits issued post-intervention (March), there were a total of 3 (42.9%) returned. Considering
that a p-value less than 0.05 is significant, there was no statistically significant difference
between the proportion of kits returned pre-intervention versus post-intervention (p=0.239).
Discussion
This project aimed to address the low compliance of FIT kit returns given to women
veteran patients in a primary care clinic. The main aims were to improve the FIT kit return rates
and establish a standard operating procedure for following up with the FIT kits given. Although
this DNP project did not yield the desired results, it did, however, reveal that more interventions
are needed to motivate patients to return the issued FIT kits. Aside from patients not returning
the FIT kits, the project also revealed that the facility’s staffing shortage contributes to patients
not being screened for colorectal cancer. The proposed process calls for nurses to review the
patients due for colorectal screenings and contact them via telephone or by letter. Adding
additional nursing tasks to overworked, burned-out nurses who already have time constraints is
arduous. It was noted that all of the pre-intervention FIT kits were given to patients while they
were in clinic. This is likely the reason for pre-intervention return rates being substantially higher
than post-intervention return rates. Convenience screening, such as screening patients who come
into the office for a primary care visit or walk-in patients, reduces the resources necessary for
screening outside of this setting.
An alarming detection was noted during the data collection process. While reviewing
patients in need of CRC preventive screening, it was noted that a total of 97 (12.1%) female
veterans were past due for their annual CRC screening. To assist the facility with decreasing this
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percentage, the DNP student not only screened patients due for March but also every individual
past due for CRC screening on the provider’s panel. Quantitative data was used to measure the
effectiveness of this project. With a p-value of 0.239, there was no statistically significant
difference between the pre- and post-intervention return FIT kit rates, see Table 2.
Patients who refused colorectal cancer screenings often cited they either felt it was
unimportant or were “turned off” by collecting their own stool and the possibility of their hand
coming in contact with fecal matter. A possible solution to this challenge would be to include
educational material that is written on a 3rd-grade level to ensure that the material is easy to
understand and comprehend, has a bigger font size, includes pictograms, and contains
individualized statistical information based on the patient’s race and age group. Stool collection
is an unsanitary process; therefore, the inclusion of gloves in each FIT kit could potentially
lessen the apprehension of one collecting their own stool. Further studies should investigate other
reasons why patients are reluctant to complete the FIT test and ways to motivate patients'
compliance.
This project revealed that continuous interventions are needed to ensure patients are
educated regarding colorectal cancer and the benefits of colorectal screening via the FIT kit.
Results of similar studies offer reassurance that with persistent efforts, an increase in return of
FIT kits can be obtained. Motivating patients to complete colorectal screenings is a continuous
challenge that requires additional resources and techniques to increase FIT kit return compliance
rates.
Implications for Clinical Practice
The project’s aim of increasing colorectal screenings was met in that 41 patients (42.2%)
from the provider’s entire panel were successfully contacted and notified of the need for CRC
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screening, thus increasing awareness of the importance of this screening. This project can
contribute to existing evidence by showing the necessity of an effective plan to increase patients’
compliance with returning FIT kits. Standardizing an effective strategy provides a resource with
simplicity and thoroughness via a guided blueprint for nurses to implement.
Implications for Quality Healthcare and Patient Safety
Quality care and patient safety are core values among healthcare institutions nationally.
Quality healthcare involves achieving the desired health outcomes while patient safety eliminates
unnecessary harm, thus preventing adverse events. Administering FIT kits demonstrates quality
care and patient safety by satisfying colorectal cancer preventive screening recommendations,
being noninvasive, containing high-level specificity, and reducing possible mortality associated
with colorectal cancer. This process improvement project demonstrated the overall improvement
of quality care provided by exhibiting the increase of returned FIT kits. Implementing a
standardized follow-up protocol for FIT kits administered builds rapport and a trusting
relationship between the patient and nurse. The patient feels a sense of caring and concern,
knowing that the nurse has taken the time to ensure the patient has completed this vital
screening.
Limitations
The main limitations of this project were the small population group, female-only gender
inclusion, and control setting. The project was performed only with women at the women’s
primary care clinic. Studying only women is not a good representation of the facility’s
population as a whole and is a significant limitation. Women tend to live healthier lifestyle habits
when compared to their male counterparts. Women with greater trust in physicians also tend to
seek healthcare more often and have longer consultation times with their providers than men
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according to Thompson et al. (2016). This tendency could feasibly be the reason for this
particular population to be agreeable to returning the FIT kits and not the communication
strategies that were implemented in the alignment of the project.
The setting for obtaining the stool sample is within the patient’s home. One limitation of
this is that there is no control over the patient’s home setting and the care of the FIT kit itself
once it is given to the patient. High ambient temperatures are associated with decreased FIT
sensitivity and positivity rates for detecting colorectal cancer. If the patient left the kit in a hot
car, out in the sun, or even if postal handlers left the kit in direct sunlight, this could potentially
alter the results obtained. Additionally, this project depended on the patient following the testing
instructions accurately and testing her own stool. Due to not being present during the sample
collection, it cannot be determined if the stool sample was obtained appropriately or even from
the patient. This project relied entirely on the patient collecting stool accurately and properly
handling the testing kit, which is a great limitation.
Another limitation is the constricted time for returning the FIT kits. Due to potential
degradation of the kits, patients were advised to return the kits within seven days preferably.
Patients who had other time-consuming obligations such as working or caring for the family may
view the time constraint as a nuisance. Due to the small sample size of patients, utilizing only
one clinic, only including women, and having limited follow-up duration, it is difficult to
determine whether the changes will sustain over time or be as effective in a different clinical
setting. Nevertheless, with ongoing interventions, results could reflect similar outcomes in more
extensive scaled studies, indicating potential on a larger scale.
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Dissemination
The findings for this project will be disseminated by means of a poster, presentation, and
scholarly written manuscript. A poster or presentation will be presented on July 15, 2022, during
the DNP dissemination conference. In addition to this, the DNP manuscript will be placed in
Jacksonville State University Digital Common’s Repository.
Plans for Future Scholarship
The implementation phase of this project required extensive time of this student. This
investigator invested 16 hours over the span of two days scrubbing the provider’s entire panel of
patients to narrow down individuals that met inclusion criteria. Investing in efficient electronic
computing systems that accurately support tracking patients synchronously reduces the need for
staff’s time to screen patients. In addition, automated notices to patients becoming due for
colorectal screening reduces the need for staff to physically generate correspondences to patients.
Due to the small size and shorter timeframe for this study group, future research can track the
longevity of this plan among larger sample sizes for a greater length of time to observe
sustainability. Increasing the sample size and length of the study may aid in identifying barriers
to continuing this protocol for an extended period of time. Furthermore, this study’s inclusion
criteria can be broadened to include male patients, which constitute the majority of the
population at this medical center.
Conclusion
Colorectal preventive screenings assist with the improvement of colorectal diagnoses
through early detection. Siegel et al. (2020) remarked that colorectal cancer is presently the
second most common cause of cancer mortality in the United States. Many patients may feel
apprehensive regarding undergoing invasive procedures such as a colonoscopy. However, FIT
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testing is non-invasive, inexpensive, and can conveniently be done within the comforts of the
patient’s home. Despite the proven benefits of screening, only 65% of age-eligible adults are up
to date in the United States, according to Cusumano and May (2020).
The importance of life-saving colorectal screenings cannot be emphasized enough. This
DNP project sought to increase participation in colorectal cancer screenings via FIT kits by
utilizing multimodal communication strategies. While this project revealed many limitations,
including a small sample size, female-only gender, and uncontrolled setting, the extensive
literature review revealed the effectiveness of utilizing multiple modes of communication to
engage patient participation in caring for his or her health. Further research should identify other
barriers to staff from completing the screenings with their patients. With continued education,
awareness of colorectal cancer, and the use of multimodal communication strategies, healthcare
officials can assist patients in closing the gap of past due preventive colorectal screenings, thus
reducing its mortality effects.
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Table 1
Inclusion and Exclusion Criteria
Inclusion and Exclusion Criteria
Inclusion Criteria
•

women patients that are
enrolled in the women’s
clinic

•

ages 45-75

•

deemed ‘average risk’

Exclusion Criteria
•

Male patients

•

Less than age 45 or greater
than age 75

•

Not deemed “average risk”

•

Recent or future
colonoscopy scheduled

•

Patients that refused
colorectal screening

•

Patients unable to be
contacted via telephone or
secure messaging
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Table 2
Statistical Analysis Report
Statistical Analysis Report
Period

Kits Issued

Kits Returned

N

n (%)

Pre-Intervention

16

11 (68.8%)

PostIntervention

7

3 (42.9%)

Difference

P-Value

25.9%

0.239
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Appendix A
IRB Approval Letter
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Appendix B
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Appendix C
Participant Consent Form
TITLE OF STUDY: Utilizing Multimodal Communication Strategies to Improve Average Risk
Women Veteran Patient Participation in Returning Colorectal Fecal Immunochemical Test kits
Principal Investigator: Shuntae Hooten
This consent form is part of an informed consent process for a DNP student project. This form
will provide information that will help you decide if you want to volunteer for this project or not.
The timeframe for data collection is 6 weeks. If you have any questions or concerns at any time,
feel free to ask them. After all of your questions and concerns have been answered, you may
proceed with participating in this project by signing the consent form below.
Why is this project being done?
The problem in current practice is that colorectal screening Fecal Immunochemical Test (FIT)
kits are being given to patients but not returned. Therefore, patients are not properly screened for
colorectal cancer. This DNP project will explore if implementing a multimodal outreach strategy
increases the return of completed FIT kits at the Birmingham Veteran Affairs Annex.
The process of the study
The average risk patients will be reviewed to determine if they have been screened for colon
cancer. The DNP student will be contacting potential participants initially via telephone or
secured messenger. Individuals that wish to not participate in this project will not be further
contacted after the initial communication, respectfully. If the patient meets average risk criteria,
consents to the project, and agrees to FIT testing, this student will then mail out a FIT test. If the
FIT test is not returned within 14 days the DNP student will follow up by contacting the patient
via phone or secure messenger to encourage the return of the completed FIT kit and to reinforce
the importance of this screening. If the patient cannot be reached via phone or secure messenger,
this student will then send a letter out to the patient’s address encouraging return of the FIT kit.
After the letter is mailed, this student will monitor if the patient returned the FIT kit for another 2
weeks. Per the facility’s policy, the colorectal cancer screening can be documented as refused if
no response is received from the patient at 30 days after distribution. The DNP student will
communicate with all participants in the manner above, that are in agreement with participating
in this project.
What will be your role in this project?
The participant’s role will be to complete the FIT kit and return it to the facility. There will be no
compensation for participating in this project. There will be no consequences for not
participating. Each participant reserves the right to withdraw at any time without penalty.
What are the risks and benefits you may experience when participating?
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There are benefits of completing preventive screenings. Preventive screenings such as Fecal
Immunochemical Test (FIT) kits have proven to be effective in identifying early signs of
colorectal cancer. When cancer is identified early, it has a greater chance of responding to
treatment therefore increasing chances of survival. The benefit of participating will reveal if
multimodal communication strategies are effective in returning of FIT kits as well as being
properly screen for colorectal cancer. The risks involved by not participating include not being
properly screened for colorectal cancer and feelings of anxiety or nervousness related to the
collection of own stool sample.
How will your information be kept confidential?
Confidentiality will be maintained by not using any personal identifiable information such as
name, birthdate and social security number. No personal identifiable information will be
published. All data collected will be stored on a secured electronic network within the facility.
Who to call if you have any questions or concerns?
If you have any questions or concerns, please contact the principal investigator Shuntae Hooten
at (205) 335-4042 or Shooten@stu.jsu.edu.
AGREEMENT TO PARTICIPATE
Participant consent:
I have read the entire description of the DNP project/study, and I understand the procedure
described on the attached pages. I also have received a copy of the description. All of my
questions and concerns have been addressed. I agree to take part of the DNP project.
_________________________ ____________________________ ____________
Name Signature

Date

Investigator:
I have explained and discussed information regarding the DNP project to the best of my ability.
All questions and concerns of the participant have been answered truthfully.
_________________________ ____________________________ ____________
Name Signature

Date
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Appendix D
Primer letter
Dear Ms._______________________
Your health is very important to the VA Health Care System. One of the most important
screenings for maintaining your health is Colorectal Cancer Screening (CRCS). The US
Preventative Services Task Force (USPSTF) has recently recommended screening for colorectal
cancer in adults aged 45-49 years. The VA will now begin colorectal cancer screening for
“average risk” individuals starting at age 45, while continuing to recommend colorectal cancer
screening in adults aged 50 to 75 years.
A person is considered at “average risk” for colon cancer if they do not have:
* A personal history of colorectal cancer or certain types of polyps
* Family history of colorectal cancer
* History of inflammatory bowel disease (Ulcerative Colitis or Crohn's disease)
* Confirmed of suspected colorectal cancer syndrome, such as familial adenomatous polyposis
(FAP) or Lynch syndrome
* History of radiation to abdomen or pelvic area to treat prior cancer
Our records indicate you have an Average Risk for colon cancer. If you are interested in FIT KIT
Testing for ColoRectal Cancer Screening, please contact your Primary PACT Team and a KIT
will be mailed to you with instructions.
If you have received colorectal cancer screening (FIT Testing, Cologuard or Colonoscopy)
through an outside provider within the last 1-10 years, please provide your PACT team with the
results, as we may not have access to those records.
If you have any further questions, you can contact your Primary Care PACT Team.
Respectfully,

44

Appendix E
Follow-up letter
Dear Ms.___________
Colorectal Cancer is the third leading cause of cancer related deaths in the U.S. The Hemoccult
FIT test you recently received is a screening test for ColoRectal Cancer that allows for early
detection when the disease is easier to treat. According to our records, you have received a FIT
KIT dated_________and have not yet returned the kit to the medical center. Please return the kit
at your earliest convenience in the prepaid postage envelope included with the KIT.
If you have lost or misplaced your FIT kit and require a new one to be mailed, please call your
Primary Care PACT Team so we can mail a new FIT kit to your address. It is important that you
contact us within the next 7 days.
Please consider completing this test to assist with achieving lifetime health and wellness. It is
our goal to provide quality care in a timely manner. If you have had a Colonoscopy, Cologuard,
or FIT Test within the last 1 to 10 years, please provide a copy of your results to us so that we
can scan your medical record.
Thank you for choosing the VA Health Care System for your healthcare needs.
Sincerely,
Your Primary Care PACT Team

